Literature DB >> 14760329

The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease.

John Spertus1, Philip Jones, Sherri Poler, Krishna Rocha-Singh.   

Abstract

BACKGROUND: The most common indication for treating patients with peripheral arterial disease is to improve their health status: their symptoms, function, and quality of life. Quantifying health status requires a valid, reproducible, and sensitive disease-specific measure. The Peripheral Artery Questionnaire (PAQ) is a 20-item questionnaire developed to meet this need by quantifying patients' physical limitations, symptoms, social function, treatment satisfaction, and quality of life.
METHODS: Psychometric and clinical properties of the PAQ were evaluated in a prospective cohort study of 44 patients undergoing elective percutaneous peripheral revascularization. To establish reproducibility, 2 assessments were performed 2 weeks apart and before revascularization. The change in scores before and 6 weeks after revascularization were used to determine the instruments' responsiveness and were compared with the Short Form-36 and the Walking Impairment Questionnaire. A series of cross-sectional analyses were performed to establish the construct validity of the PAQ.
RESULTS: The 7 domains of the PAQ were internally reliable, with Cronbach alpha = 0.80 to 0.94. The test-retest reliability analyses revealed insignificant mean changes of 0.6 to 2.3 points (P = not significant for all). Conversely, the change after revascularization ranged from 13.7 to 41.9 points (P < or =.001 for all), reflecting substantial sensitivity of the PAQ to clinical improvement. The PAQ Summary Scale was the most sensitive of all scales tested. Construct validity was established by demonstrating correlations with other measures of patient health status.
CONCLUSIONS: The PAQ is a valid, reliable, and responsive disease-specific measure for patients with peripheral arterial disease. It may prove to be a useful end point in clinical trials and a potential aid in disease management.

Entities:  

Mesh:

Year:  2004        PMID: 14760329     DOI: 10.1016/j.ahj.2003.08.001

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  33 in total

1.  Exercise therapy for claudication: latest advances.

Authors:  Ryan J Mays; Judith G Regensteiner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04

Review 2.  Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.

Authors:  Mary McGrae McDermott
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

3.  Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).

Authors:  Manesh R Patel; Michael S Conte; Donald E Cutlip; Nabil Dib; Patrick Geraghty; William Gray; William R Hiatt; Mami Ho; Koji Ikeda; Fumiaki Ikeno; Michael R Jaff; W Schuyler Jones; Masayuki Kawahara; Robert A Lookstein; Roxana Mehran; Sanjay Misra; Lars Norgren; Jeffrey W Olin; Thomas J Povsic; Kenneth Rosenfield; John Rundback; Fadi Shamoun; James Tcheng; Thomas T Tsai; Yuka Suzuki; Pascal Vranckx; Bret N Wiechmann; Christopher J White; Hiroyoshi Yokoi; Mitchell W Krucoff
Journal:  J Am Coll Cardiol       Date:  2015-03-10       Impact factor: 24.094

4.  Heterogeneity of Ankle-Brachial Indices in Patients Undergoing Revascularization for Critical Limb Ischemia.

Authors:  Devraj Sukul; Scott F Grey; Peter K Henke; Hitinder S Gurm; P Michael Grossman
Journal:  JACC Cardiovasc Interv       Date:  2017-11-27       Impact factor: 11.195

5.  Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.

Authors:  Timothy P Murphy; Matthew R Reynolds; David J Cohen; Judith G Regensteiner; Joseph M Massaro; Donald E Cutlip; Emile R Mohler; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Suzanne Goldberg; Alan T Hirsch
Journal:  J Vasc Interv Radiol       Date:  2013-07-29       Impact factor: 3.464

6.  Edetate Disodium-Based Treatment in a Patient With Diabetes and Critical Limb Ischemia After Unsuccessful Peripheral Arterial Revascularizations: A Case Report.

Authors:  Francisco Ujueta; Ivan A Arenas; Timothy Yates; Robert Beasley; Denisse Diaz; Gervasio A Lamas
Journal:  Clin Diabetes       Date:  2019-07

7.  Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

Authors:  Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Michael R Jaff; Anthony J Comerota; Michael W Steffes; Ingrid H Abrahamsen; Suzanne Goldberg; Alan T Hirsch
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

8.  Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease.

Authors:  Yevgeniy Khariton; Krishna K Patel; Paul S Chan; Yashashwi Pokharel; Jingyan Wang; John A Spertus; David M Safley; William R Hiatt; Kim G Smolderen
Journal:  Clin Cardiol       Date:  2018-10-19       Impact factor: 2.882

Review 9.  Community walking programs for treatment of peripheral artery disease.

Authors:  Ryan J Mays; R Kevin Rogers; William R Hiatt; Judith G Regensteiner
Journal:  J Vasc Surg       Date:  2013-10-05       Impact factor: 4.268

10.  Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization).

Authors:  Yashashwi Pokharel; Philip G Jones; Garth Graham; Tracie Collins; Judith G Regensteiner; Timothy P Murphy; David Cohen; John A Spertus; Kim Smolderen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.